CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $41.90, but opened at $44.36. CochLear shares last traded at $44.05, with a volume of 1,775 shares traded.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CHEOY. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.
Get Our Latest Report on CHEOY
CochLear Trading Down 1.8%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
- Five stocks we like better than CochLear
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
